Does heart rate affect the prognosis of patients with hypertension and other cardiovascular diseases? Review article

Article Sidebar

Requires Subscription PDF (Język Polski)


Published: Sep 30, 2021
Keywords:
heart rate, hypertension, cardiovascular complications, β-adrenolytics, bisoprolol, perindopril

Main Article Content

Jacek Lewandowski
Katedra i Klinika Chorób Wewnętrznych, Nadciśnienia Tętniczego i Angiologii, Warszawski Uniwersytet Medyczny

Abstract

Elevated heart rate, both in healthy people and in patients with cardiovascular diseases significantly increases the risk of cardiovascular complications. Elevated heart rate occurs in a high percentage of patients with arterial hypertension. Early identification of patients with tachycardia and their treatment is essential. Among the drugs used to treat elevated heart rate, β-blockers hold a special place. Since single pills combinations are recommended in therapy of hypertension, it is worth considering the use of a combination of bisoprolol and perindopril. The effectiveness of these drugs in reduction of cardiovascular complications has been proven in numerous studies in various groups of patients.

Downloads

Download data is not yet available.

Article Details

How to Cite
Lewandowski , J. (2021). Does heart rate affect the prognosis of patients with hypertension and other cardiovascular diseases?. Cardiology in Practice, 15(1-2), 26-31. Retrieved from https://journalsmededu.pl/index.php/kwp/article/view/1495
Issue
Vol 15 No 1-2 (2021)
Section
Pharmacology in cardiological practice
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright: © Medical Education sp. z o.o. This is an Open Access article distributed under the terms of the Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). License (https://creativecommons.org/licenses/by-nc/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.

Address reprint requests to: Medical Education, Marcin Kuźma (marcin.kuzma@mededu.pl)

References

1. Spodick DH. Normal sinus heart rate: sinus tachycardia and sinus bradycardia redefined. Am Heart J. 1992; 124(4): 1119-21.
2. Quer G, Gouda P, Galarnyk M et al. Inter- and intraindividual variability in daily resting heart rate and its associations with age, sex, sleep, BMI, and time of year: Retrospective, longitudinal cohort study of 92,457 adults. PLoS One. 2020; 15(2): e0227709.
3. Levy RL, White PD. Transient tachycardia; prognostic significance alone and in association with transient hypertension. Med Press Egypt. 1946; 38(6): 207-12.
4. Inoue T, Oshiro S, Iseki K et al. High heart rate relates to clustering of cardiovascular risk factors in a screened cohort. Jpn Circ J. 2001; 65(11): 969-73.
5. Palatini P, Dorigatti F, Zaetta V et al. Heart rate as a predictor of development of sustained hypertension in subjects screened for stage 1 hypertension: the HARVEST Study. J Hypertens. 2006; 24(9): 1873-80.
6. Farinaro E, Stranges S, Guglielmucci G et al. Heart rate as a risk factor in hypertensive individuals. The Italian TensioPulse Study. Nutr Metab Cardiovasc Dis. 1999; 9(4): 196-202.
7. Morcet JF, Safar M, Thomas F et al. Associations between heart rate and other risk factors in a large French population. J Hypertens. 1999; 17(12 Pt 1): 1671-6.
8. Palatini P, Julius S. Relevance of heart rate as a risk factor in hypertension. Curr Hypertens Rep. 1999; 1(3): 219-24.
9. Julius S, Palatini P, Kjeldsen SE et al. Usefulness of heart rate to predict cardiac events in treated patients with high-risk systemic hypertension. Am J Cardiol. 2012; 109(5): 685-92.
10. Jouven X, Zureik M, Desnos M et al. Resting heart rate as a predictive risk factor for sudden death in middle-aged men. Cardiovasc Res. 2001; 50(2): 373-8.
11. Gillman MW, Kannel WB, Belanger A et al. Influence of heart rate on mortality among persons with hypertension: the Framingham Study. Am Heart J. 1993; 125(4): 1148-54.
12. King DE, Everett CJ, Mainous AG et al. Long-term prognostic value of resting heart rate in subjects with prehypertension. Am J Hypertens. 2006; 19(8): 796-800.
13. Diaz A, Bourassa MG, Guertin MC et al. Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J. 2005; 26(10): 967-74.
14. Fox K, Ford I, Steg PG et al. Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial. Lancet. 2008; 372(9641): 817-21.
15. Nabel EG, Selwyn AP, Ganz P. Paradoxical narrowing of atherosclerotic coronary arteries induced by increases in heart rate. Circulation. 1990; 81(3): 850-9.
16. Palatini P, Rosei EA, Casiglia E et al. Management of the hypertensive patient with elevated heart rate: Statement of the Second Consensus Conference endorsed by the European Society of Hypertension. J Hypertens. 2016; 34(5): 813-21.
17. Williams B, Mancia G, Spiering W et al. 2018 Practice Guidelines for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology: ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens. 2018; 36(12): 2284-309.
18. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet. 1999; 353(9146): 9-13.
19. Bertrand ME, Ferrari R, Remme WJ et al. Perindopril and beta-blocker for the prevention of cardiac events and mortality in stable coronary artery disease patients: A EUropean trial on Reduction Of cardiac events with Perindopril in stable coronary Artery disease (EUROPA) subanalysis. Am Heart J. 2015; 170(6): 1092-8.